Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
January 23, 2020As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...
Read more
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
October 30, 2019Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...
Read more
Chhattisgarh: Treating tuberculosis in the jungle
October 29, 2019Since 2006, MSF is working in Sukma district of Southern Chhattisgarh in India, place of a longstanding low-intensity conflict between Indian security forces and Left-Wing Extremist group. The MSF team works to provide primary health care services to the population...
Read more
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
October 10, 2019GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...
Read more
Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?
August 15, 2019GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...
Read more
Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients
July 30, 2019When Thongsei Lupho, 44, first started feeling unwell, he suspected he had contracted Tuberculosis. He visited MSF’s clinic in Moreh, on the Indo-Myanmar border, where he was diagnosed with HIV. Lupho had used drugs in the past to gain social...
Read more
World Tuberculosis Day: Treating the untreatable
March 24, 2019With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read more
Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
March 24, 2018Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). Pooja,...
Read more
MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
November 20, 2017At High Court of Delhi hearing tomorrow, Doctors Without Borders/Médecins Sans Frontières (MSF) will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine New York/ New Delhi, November 20, 2017 —...
Read more
India skips 6 Of 16 key WHO recommendations on TB
August 12, 2017India does not implement six out of the 16 key World Health Organisation (WHO)- recommended tuberculosis (TB) control policies in diagnosis, patient care and treatment, a new global report has found. Four other policies that are a part of the national policy...
Read more
